UNSPSC 85502118: Supplement left subclavian artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left subclavian artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U437Z

UNSPSC 85502118 Supplement left subclavian artery with autologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its clinical-procedure scope. The code's nominal description targets a specific surgical intervention (left subclavian artery supplementation using autologous tissue via percutaneous technique), yet the state and local opportunities tagged to this code encompass occupational health surveillance, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical center-of-excellence carve-out programs, and temporary health professional staffing — none of which involve the described vascular procedure or match the procedural focus of the code itself. The mismatch suggests either miscoding in the source data or that this particular UNSPSC code does not reflect actual state and local procurement patterns.

The six opportunities present span Arizona, California, Washington, Florida, and Texas, issued by a city retirement office, two municipal health systems, a state transportation department, a county probation department, and a county human resources division. The absence of recent solicitations for the specific procedure named in the code's definition indicates that state and local procurement under this Commodity does not generate meaningful contract volume, or the opportunities currently posted are genuinely unrelated to subclavian artery procedures. A business development professional evaluating this code should treat it as dormant for state and local purposes unless downstream market research surfaces procedures-aligned opportunities outside this dataset.